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1. Introduction 
Equine Herpesvirus 9 (EHV-9) is a new member of the equine herpesviruses which was 
isolated from Thomson’s gazelles (Gazella thomsoni) that died of fulminant encephalitis in a 
Japanese zoo (Fukushi et al., 1997; Yanai et al., 1998). Previously, experimental infections of 
EHV-9 were conducted in various species of animals other than primates to clarify the 
infectivity and virulence of this virus and to assess the emerging aspects of EHV-9 in zoo 
and domestic animal populations. EHV-9 caused fatal infections with fulminant encephalitis 
characterized by neuronal degeneration and necrosis as well as intra-nuclear inclusion 
bodies in rodents (Fukushi et al., 1997; Fukushi et al., 2000), goats (Taniguchi et al., 2000), 
pigs (Narita et al., 2000, 2001), dogs (Yanai et al., 2003a) and cats (Yanai et al., 2003b). Based 
on several experimental studies of EHV-9 involving various domestic animals such as dogs 
and cats often found in close proximity to humans, there were grave concerns that EHV-9 
could be transmitted to humans through contact with affected animals or zebras through 
certain routes. In order to assess the risk of EHV-9 to humans, we tried to determine the 
infectivity of EHV-9 in non-human primates, including common marmosets (Callithrix 
jacchus) and cynomolgus macaques (Macaca fasciocularis), which have strong similarities to 
humans, using the nasal route.  
2. Marmosets 
One female and four male common marmosets, aged 2 to 4 years old and weighing 285-
368g, were used for this assessment (Kodama et al., 2007). Four of the marmosets were 
inoculated intranasally with 1ml of EHV-9 virus solution containing 106 plaque-forming 
units. The other was inoculated with 1 ml of MEM as a negative control. The inoculated 
animals were humanely euthanatized on Days 3, 4 and 5 following inoculation, respectively, 
at a point when they were in poor condition or dying from a neuronal disorder. The virus 
was recovered and identified by polymerase chain reaction (PCR) with the primers targeting 
the EHV-9 specific region of the EHV-9 gene. The PCR primers used for amplification were 
5’-CTGGGTTATAGATTGTCGCCTC-3’ and 5’-CCCAGAAAGTATTACACGCGAT-3’. The 
neutralization test was done using the 50% plaque reduction method with the MDBK cell 
monolayer. 
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All four of the inoculated animals exhibited various neurological signs and finally collapsed. 
From the second day post-inoculation (dpi), all four inoculated marmosets began to exhibit 
signs of anorexia and depression. A decrease in body weight was noted from 3 dpi. At 3 dpi, 
rectal temperatures in each of the treated animals were approximately 2 to 3 degrees lower 
than those in the non-treated control animal, although the animals recovered from the 
hypothermia the following day. From 3 to 5 dpi, the inoculated animals showed varying 
degrees of neurological signs consisting of salivation (Fig. 1), star gazing, convulsions and 
finally coma. At 4 and 5 dpi the animals refused food, became severely depressed, and 
collapsed. One animal was euthanized based on schedule, but two animals were euthanized 
at 3 dpi due to poor condition, and the last one was euthanized at 5 dpi. The control animal 
was euthanized at 6 dpi. 
 
 
Fig. 1. Marked salivation with a large amount of foamy saliva at 4 dpi. 
At necropsy, no significant abnormalities were observed in the external or visceral organs in 
any of the inoculated animals.  
Histologically, the affected animals had severe encephalitis characterized by neuronal 
degeneration and necrosis with intra-nuclear inclusions, which extended from the olfactory 
bulb to the rhinencephalon and piriform lobe. The nuclei of affected degenerating neuronal 
cells exhibited severe degrees of chromatolysis or karyorrhexis, eventually resulting in 
neuronal loss and cellular debris (Fig. 2). The degenerating neuronal cells had frequent 
intra-nuclear inclusion bodies which were equivalent to herpesvirus in morphology, 
appearing as full-inclusion or Cowdry type A inclusions (Figs. 2 and 3). The inclusion 
bodies were particularly frequent in the olfactory bulb, piriform lobe and amygdaloid body 
in the affected animals. Cerebrum lesions were observed in all layers of the olfactory bulb, 
the piriform lobe (Fig. 4) and a part of the temporal lobe in an animal euthanized at 3 dpi. 
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The lesions then spread to the basal ganglia, except for the globus pallidus, and the limbic 
lobe, including the hippocampus and cingulate gyrus, basal forebrain and temporal lobe in 
the animals (Fig. 5). The animal euthanized at 5 dpi had widely distributed lesions in the 
cerebrum. No abnormalities were observed in the cerebellum or spinal cord. 
Immunohistochemistry to EHV-9 antibody revealed positive reactions in the nucleus, intra-
nuclear inclusions and the cytoplasm in degenerating neuronal cells, and occasionally in 
normal-appearing neuronal cells in the marginal zone or surroundings of affected areas in 
the brain (Fig. 6). Prominent inclusion bodies appearing as the full-inclusion type had the 
most intensely positive reaction around the nuclear membrane. 
 
 
Fig. 2. Olfactory bulb; Neuronal necrosis with intra-nuclear inclusion bodies, appearing as 
Cowdry type A (arrow) or full-inclusion (arrow head) inclusions. HE. Bar=3.5μm. 
 
 
Fig. 3. Olfactory bulb; Frequent intra-nuclear inclusions. HE. 
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Fig. 4. Piriform lobe; Neuronal degeneration and necrosis with intra-nuclear inclusions. 
 
 
 
 
Fig. 5. Time-course extension of EHV-9 induced encephalitis in the brain. 
www.intechopen.com
 Equine Herpesvirus 9 (EHV-9) Induced Encephalitis in Nonhuman Primates 151 
 
Fig. 6. Olfactory bulb. Most neuronal cells in all layers of the glomerular, mitral and granule 
layers are frequently positive to EHV-9 antigen. ABC method. Bar=5.7μm. 
Immunostaining for EHV-9 antigen. Frequent positive reactions. 
In the nasal cavities of all of the animals inoculated with EHV-9, there was severe 
necrotizing rhinitis characterized by severe necrosis of the olfactory epithelium and 
olfactory glands in the olfactory area (Fig. 7). The marmosets that had been inoculated 
exhibited more severe desquamation of the olfactory epithelium, as well as degeneration 
and necrosis at 3 dpi. In addition, occasional olfactory Schwann cells were degenerative or 
necrotic. Frequent intra-neuronal inclusion bodies were seen in the degenerating epithelial 
cells in both the olfactory epithelium and olfactory glandular epithelium (Fig. 8). In the 
respiratory area, sight focal necrosis and ablation were occasionally observed in the mucosa. 
Immunohistochemically, there were frequent positive reactions in both intra-nuclear 
inclusion bodies and the cytoplasm of degenerating cells in the olfactory epithelium and 
olfactory glandular epithelium in all animals inoculated with EHV-9 (Figs. 9, 10). Occasional 
degenerating mucosal epithelium in the respiratory area and degenerating Schwann cells 
also had positive reactions.  
 
 
Fig. 7. Olfactory area in the nasal cavity; The degenerating epithelial epithelium and 
olfactory glandular epithelium with frequent intranuclear inclusions. HE. Bar = 8.6 μm 
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Fig. 8. Olfactory area in the nasal cavity; Frequent intra-neuronal inclusion bodies are seen 
epithelium and olfactory glandular epithelium. HE. 
 
 
 
 
 
 
 
Fig. 9. Olfactory area in the nasal cavity; Positive reaction is seen in the degenerating 
epithelial cells in both the olfactory epithelium and olfactory glandular epithelium. 
Immunohistochemical stain for EHV-9. ABC method. Bar=8.6μm. 
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Fig. 10. Olfactory area in the nasal cavity; Positive reaction is seen at the intra-nuclear 
inclusion bodies (arrows), nucleus and cytoplasm (arrow head) in the degenerating olfactory 
glandular epihelial cells. Immunohistochemical stain for EHV-9. ABC method. Bar=3.3μm. 
EHV-9 was recovered from the olfactory bulb and frontal lobe in all inoculated marmosets. 
In addition, EHV-9 was isolated from the lung in one marmoset and from the salivary gland 
and mandible lymph node in one marmoset. The recovered virus was confirmed to be EHV-
9 by the PCR method. The EHV-9 virus was not neutralized by 4-times dilution serum in the 
neutralization test. No virus was isolated from other organs or blood. 
EHV-9 demonstrated ready infectivity and rapid progression of the disease in marmosets, 
which indicates the possibility of EHV-9 infectivity in primates, including humans, as in 
other domestic animals and rodents. Nasal inoculation of EHV-9 resulted in varying degrees 
of encephalitis in a wide variety of animals, including rodents, domestic ruminants and 
companion animals. As with other novel herpesvirus infections such as pseudorabies virus 
infection in dogs (Yanai et al., 2003a) and B virus infection in humans (Adam and Graham, 
1994), EHV-9 could possibly be more virulent in unusual hosts than in the natural host. The 
pathogenicity of EHV-9 to humans is currently unknown; however, we may be able to 
assess the virulence of EHV-9 in humans to a certain extent by using nonhuman primates as 
a model because nonhuman primates have many infectious diseases in common with 
humans. It was estimated that EHV-9 could possibly be pathogenic to humans if nonhuman 
primates were infected with it. We used common marmosets for the experimental infection 
of EHV-9 because they are commonly used for experiments and because they are known to 
be susceptible to some herpesviruses. Generally, nonhuman primates are highly susceptible 
to cross-species infectivity by human alpha-herpesvirus, including herpes simplex virus 
(HSV). In new world monkeys, HSV causes outbreaks characterized by severe ulcerative 
gingivostomatitis and encephalitis, and these outbreaks are quick to occur in zoo-housed 
marmosets, with marmosets being thought to be highly susceptible to HSV (Matz-Rensing et 
al., 2003). On the other hand, simian herpes virus, Herpesvirus B (Cercopithecine 
herpesvirus 1), has been implicated as the cause of approximately 40 cases of 
meningoencephalitis affecting persons in direct or indirect contact with laboratory 
macaques (Weigler, 1992).  
In marmosets, as in other animals, EHV-9 shows strong neurotropism and causes selective 
neuronal necrosis. The distribution of lesions and the virus are most similar to those in cats 
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(Yanai et al., 2003b). As the most severely affected area was the olfactory bulb, the virus 
inoculated into the nasal cavity gained access to the olfactory bulb and then progressed 
along the rhinencephalon over time. In our study, all of the marmosets inoculated 
intranasally had severe rhinitis with intranuclear inclusions, and EHV-9 antigen was 
detected in the olfactory epithelium and glands. From these findings, the EHV-9 inoculated 
into the nasal cavity presumably multiplied in the olfactory mucosa, and then intruded into 
the nerve sheath connected to the olfactory bulb, going through the foramina in the 
cribriform plate of the ethmoid bone. As the olfactory epithelium is usually covered by 
secreta produced in the olfactory glands, the question remains of how the virus infected the 
epithelial and glandular cells. The inclusion body formation in the glandular epithelium 
indicated that a large amount of EHV-9 virus had multiplied in the olfactory glands and 
shed into the nasal cavity. This suggests that, once EHV-9 has infected the nasal mucosa, the 
marmoset sheds a large enough quantity of virus for transmission to another animal when 
contact occurs. In addition, a smaller amount of the virus may cause rhinitis with viral 
propagation once the virus intrudes into the nasal cavity. However, in the present study, it 
was not clear how the nerve axons were affected by the EHV-9 in the olfactory mucosa, or 
how the virus in the nerve sheath migrated to the olfactory bulb. 
The study demonstrated that marmosets can be infected by a larger dose of EHV-9 by the 
intranasal route. It suggests the possibility that EHV-9 might be transmitted to other 
primates, including macaques, great apes and humans. EHV-9 might also be easily 
transmitted via the nasal route to immuno-compromised animals and patients such as AIDS 
patients. A recent study showed that Burchell’s zebras (Equus burchelli) in Tanzania had a 
high seroprevalence to EHV-9 or to viruses serologically similar to EHV-9 (Borcher et al., 
2005), which suggested that EHV-9 is present in zebras permanently residing in East Africa. 
Also, there has been some possibility of an outbreak of EHV-9 infection as an emerging 
infection in immuno-compromised animals and patients. 
3. Cynomolgus macaques  
One male and four female cynomolgus macaques were obtained from a commercial breeder 
(Kodama et al., 2011). All of the animals were free from pathogens such as salmonella and 
Mycobacterium spp. and passed the viral antibody tests for B virus and measles virus. The 
animals were divided into two groups consisting of Nos. 1 and 2 in one group and Nos. 3 
and 4 in the other, and the two groups were inoculated intranasally with 1 ml of EHV-9 
virus solution containing 103 and 106 plaque-forming units, respectively. The virus fluid was 
prepared by propagating the fifth passage of the original stock, which is in Madin-Darby 
bovine kidney (MDCK) cells, in fetal horse kidney cells. The infectivity of the inoculums was 
confirmed by virus plaque assay with MDCK cells. As a control, cynomolgus monkey No. 5 
was inoculated with 1 ml of minimal essential medium. Animals Nos. 1 and 3 were 
euthanized in accordance with animal welfare regulations on 6 dpi. The other animals were 
euthanized on 10 dpi.   
In contrast with the control animal, the inoculated animals began avoiding light starting 
from 4 dpi. Blood studies showed no hematological abnormalities in any of the animals.  
At necropsy, no significant abnormalities were observed in any organs from any of the 
animals.  
Histopathologically, no significant pathological changes were observed in any of the organs 
from any of the animals. Immunohistochemistry revealed no positive reactions in any of the 
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organs or tissues, including the nasal cavities or brains of the animals. In the amplification of 
the gene for gB (ORF33) using specific primers for EHV-9 by PCR, no bands were detected 
in any of the samples from the right olfactory bulb, right cerebrum or right cerebellum, the 
blood samples, or the nasal swabs. It was demonstrated that the nasal swabs had no 
infectivity. The EHV-9 virus was not neutralized by the serum from any of the animals in 
the neutralization test. 
The results in this study suggest that EHV-9 may be non-pathogenic for adult cynomolgus 
monkeys. The etiology for the clinical symptom was not apparent because there were no 
histopathological changes. However, the symptom may have been a response to the EHV-9 
inoculation. 
Although lethal encephalitis was induced via the nasal, oral, intraperitoneal and ocular 
routes of EHV-9 inoculation in hamsters (El-Habashi et al., 2010), the intranasal route may 
be the most probable one. In addition, EHV-9 replicated in the olfactory epithelium and 
olfactory glandular epithelium in common marmosets (Kodama et al., 2007). Based on those 
results, successful infection to the olfactory epithelium might be among the essential factors 
for following EHV-9 induced encephalitis. The proportion of surface area covered by the 
olfactory epithelium in macaques may be considerably smaller than that in rodents and 
dogs (Herkema, 1991). Thus, there may be constitutional barriers to the entrance of the 
EHV-9 into the olfactory epithelium. However, because it has been suggested that the 
relative amount of the olfactory epithelium in common marmosets is much closer to that of 
macaques than that of rats, the constitutional distinction may not be associated with EHV-9 
infection induced via the intranasal route (Wako et al., 1999).  
4. Conclusion: EHV-9 can induce encephalitis in primates, including humans 
In assessments of infectivity of EHV-9 in nonhuman primates, there were different results 
between new world and old world monkeys. While EHV-9 caused fulminant encephalitis, 
no infectivity was seen in cynomolgus macaques. It is still uncertain whether macaques have 
barriers to invasion of EHV-9 at the entrance, and this could apply to humans as well. Thus, 
it has not been determined that EHV-9 can cross the species barrier between new world and 
old world monkeys and humans. It is also uncertain whether EHV-9 can infect immune-
compromised patients like AIDS patients, infants or elderly people. Ocular transmission of 
viruses to the CNS has been suspected in many viral diseases such as Cercopithecine herpes 
virus 1 (B-virus) in humans (CDC, 1999). Fatal infection by B-virus in humans via ocular 
exposure from biological fluid from macaque monkeys has been reported (CDC, 1999). 
Further studies using nonhuman primates may be needed to assess the risk to infants from 
the ocular route of infection. 
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